Advertisement

Advertisement

ENVB Stock Latest News

Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

The FlyPsychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

Enveric Biosciences secures new U.S. patent for its EVM301 series

PremiumThe Fly

Enveric Biosciences secures new U.S. patent for its EVM301 series

15d ago

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

PremiumThe Fly

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

27d ago

Enveric Biosciences announces registration of five trademarks in Canada

PremiumThe Fly

Enveric Biosciences announces registration of five trademarks in Canada

28d ago

Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial

PremiumThe Fly

Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial

2M ago

Enveric Biosciences announces withdrawal of petition against patent

PremiumThe FlyEnveric Biosciences announces withdrawal of petition against patent

2M ago

Enveric Biosciences reports EB-003 receptor engagement assay data

The Fly

Enveric Biosciences reports EB-003 receptor engagement assay data

2M ago

Enveric Biosciences files to sell 328,802 shares of common stock for holders

The Fly

Enveric Biosciences files to sell 328,802 shares of common stock for holders

2M ago

Enveric Biosciences Expands At-The-Market Equity Offering Capacity

PremiumCompany Announcements

Enveric Biosciences Expands At-The-Market Equity Offering Capacity

2M ago

Psychedelic: Analyst raises Compass, Definium, GH Research price targets

PremiumThe Fly

Psychedelic: Analyst raises Compass, Definium, GH Research price targets

3M ago

Enveric Biosciences expands agreement with Totec through license pact

PremiumThe Fly

Enveric Biosciences expands agreement with Totec through license pact

3M ago

Enveric Biosciences Raises Capital Through Equity Offering

PremiumCompany Announcements

Enveric Biosciences Raises Capital Through Equity Offering

3M ago

Enveric to sell 328,802 shares at $4.41 in registered direct offering

PremiumThe FlyEnveric to sell 328,802 shares at $4.41 in registered direct offering

3M ago

Enveric Biosciences Releases Updated Investor Presentation Materials

Company Announcements

Enveric Biosciences Releases Updated Investor Presentation Materials

3M ago

Enveric Biosciences announces issuance of U.S. patent

The Fly

Enveric Biosciences announces issuance of U.S. patent

4M ago

Enveric Biosciences files to sell 882,627 shares of common stock for holders

PremiumThe Fly

Enveric Biosciences files to sell 882,627 shares of common stock for holders

4M ago

Enveric Biosciences Secures $3.1M Through Warrant Exercise

PremiumCompany Announcements

Enveric Biosciences Secures $3.1M Through Warrant Exercise

4M ago

Enveric Biosciences trading resumes

PremiumThe Fly

Enveric Biosciences trading resumes

4M ago

Enveric Biosciences announces exercise of warrants for $3.1M gross proceeds

PremiumThe Fly

Enveric Biosciences announces exercise of warrants for $3.1M gross proceeds

4M ago

Enveric Biosciences trading halted, volatility trading pause

PremiumThe FlyEnveric Biosciences trading halted, volatility trading pause

4M ago

Enveric Biosciences Approves Key Stockholder Proposals

Company Announcements

Enveric Biosciences Approves Key Stockholder Proposals

4M ago

Psychedelic: Atai Beckley granted U.S. patent for EMP-01

The Fly

Psychedelic: Atai Beckley granted U.S. patent for EMP-01

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >